October 20, 2015 : DCMS #263

DISASTERS AVERTED — Near Miss Case Studies

Prevention Education About More Than Diabetes Complications

HOMERUN SLIDES — Great Clinical Presentation Highlights

The Present and Future of Insulin Therapy Part 12

CLINICAL GEMS — The Best from Diabetes Texts

Practical Diabetes Care, 3rd Ed., Excerpt #35: Lipids Part 5 of 6

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Dr. Paresh Dandona, Part 2: Advancements in Diabetes Care

MOST POPULAR ARTICLES OF THE MONTH

#1  Bacterial Link Between Heart Disease and Gum Disease Clarified
#2 FDA Approves New Long-Acting Insulin: Tresiba and Ryzodeg
#3 Artificial Pancreas for Type 1 Diabetes

This week our Home Run Slides lay out a roadmap for insulin intensification, and the use of GLP-1 analogs and DPP4-I with insulin. If you follow the path your patients can safely intensify therapy with a greatly reduced risk of hypoglycemia. You can learn even more about all the different insulins with our  comprehensive list of insulins. Click here to become an insulin expert. (Remember, this and our other “Tools for Your Practice,” are now subscriber-exclusive to reward our loyal readers. In order to access this content, you will need to register your subscription email on the new website.)

What would you do with a female, 58 years of age on a daily GLP-1 agonist, SGLT-2, metformin, not reaching goal? Click here to learn what not to do in this week’s Disaster Avoided.

Announcements:

There’s still time to enter the Diabetes In Control contest! We’d like to hear your best suggestions to help prevent insulin errors at home, at pharmacies, and in the hospital. The contestant who submits the winning idea will receive a $100 Amazon gift card! Click here for more information and to enter! You may submit as many entries as you wish. Deadline to enter is November 1^st.

Your partner in diabetes care,
Dave Joffe
Editor-in-chief

Female, 58 years of age. On a daily GLP-1 agonist, SGLT-2, metformin, not reaching goal. Started long-acting insulin, using insulin pen. Some improvements, but post prandials still elevated.

In this week’s Homerun Slides, approaches to intensifying therapy in patients who are using basal insulin but are not yet at goal.

Statins in renal disease: ezetimibe and fibric acid drugs.

Dr. Paresh Dandona, Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Buffalo, The State University of New York, continues his discussion with Associate Medical Editor Joy Pape at the 2015 ADA Sessions in Boston. This week, he shares his thoughts on the greatest advancements in diabetes care.

A bacterial species common to both diseases increases arterial inflammation by altering gene expression.

FDA approved new long-acting insulin degludec for treatments of diabetes mellitus.

Closed-loop system at home over 12 weeks feasible in type 1 patients.